These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 28256042)
1. The AlloMap™ genomic biomarker story: 10 years after. Deng MC Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28256042 [TBL] [Abstract][Full Text] [Related]
2. Randomized pilot trial of gene expression profiling versus heart biopsy in the first year after heart transplant: early invasive monitoring attenuation through gene expression trial. Kobashigawa J; Patel J; Azarbal B; Kittleson M; Chang D; Czer L; Daun T; Luu M; Trento A; Cheng R; Esmailian F Circ Heart Fail; 2015 May; 8(3):557-64. PubMed ID: 25697852 [TBL] [Abstract][Full Text] [Related]
3. Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial. Pham MX; Deng MC; Kfoury AG; Teuteberg JJ; Starling RC; Valantine H J Heart Lung Transplant; 2007 Aug; 26(8):808-14. PubMed ID: 17692784 [TBL] [Abstract][Full Text] [Related]
4. Myocardial Gene Expression Profiling to Predict and Identify Cardiac Allograft Acute Cellular Rejection: The GET-Study. Bodez D; Hocini H; Tchitchek N; Tisserand P; Benhaiem N; Barau C; Kharoubi M; Guellich A; Guendouz S; Radu C; Couetil JP; Ghaleh B; Dubois-Randé JL; Teiger E; Hittinger L; Levy Y; Damy T PLoS One; 2016; 11(11):e0167213. PubMed ID: 27898719 [TBL] [Abstract][Full Text] [Related]
5. Performance of gene-expression profiling test score variability to predict future clinical events in heart transplant recipients. Crespo-Leiro MG; Stypmann J; Schulz U; Zuckermann A; Mohacsi P; Bara C; Ross H; Parameshwar J; Zakliczyński M; Fiocchi R; Hoefer D; Deng M; Leprince P; Hiller D; Eubank L; Deljkich E; Yee JP; Vanhaecke J BMC Cardiovasc Disord; 2015 Oct; 15():120. PubMed ID: 26452346 [TBL] [Abstract][Full Text] [Related]
6. Risk evaluation using gene expression screening to monitor for acute cellular rejection in heart transplant recipients. Moayedi Y; Foroutan F; Miller RJH; Fan CS; Posada JGD; Alhussein M; Tremblay-Gravel M; Oro G; Luikart HI; Yee J; Shullo MA; Khush KK; Ross HJ; Teuteberg JJ J Heart Lung Transplant; 2019 Jan; 38(1):51-58. PubMed ID: 30352779 [TBL] [Abstract][Full Text] [Related]
7. Down regulation of protective genes is associated with cellular and antibody-mediated rejection. Lin-Wang HT; Cipullo R; Dinkhuysen JJ; Finger MA; Rossi JM; Correia EB; Hirata MH Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28752907 [TBL] [Abstract][Full Text] [Related]
8. Heart transplant Recipients' perspectives on invasive versus Non-invasive graft failure surveillance Methods. Jamil AK; Tecson KM; Ganz TT; Blankenship S; Felius J; Carey SA; Hall SA Heart Lung; 2023; 57():41-44. PubMed ID: 36027738 [TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II. Crespo-Leiro MG; Stypmann J; Schulz U; Zuckermann A; Mohacsi P; Bara C; Ross H; Parameshwar J; Zakliczyński M; Fiocchi R; Hoefer D; Colvin M; Deng MC; Leprince P; Elashoff B; Yee JP; Vanhaecke J Eur Heart J; 2016 Sep; 37(33):2591-601. PubMed ID: 26746629 [TBL] [Abstract][Full Text] [Related]
10. A Review of Biomarkers of Cardiac Allograft Rejection: Toward an Integrated Diagnosis of Rejection. Coutance G; Desiré E; Duong Van Huyen JP Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009029 [TBL] [Abstract][Full Text] [Related]
11. The utilization of molecular microscope in management of heart transplant recipients in the era of noninvasive monitoring. Mehlman Y; Valledor AF; Moeller C; Rubinstein G; Lotan D; Rahman S; Oh KT; Bae D; DeFilippis EM; Lin EF; Lee SH; Raikhelkar JK; Fried J; Theodoropoulos K; Colombo PC; Yuzefpolskaya M; Latif F; Clerkin KJ; Sayer GT; Uriel N Clin Transplant; 2023 Dec; 37(12):e15131. PubMed ID: 37897211 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection. Karason K; Jernås M; Hägg DA; Svensson PA BMC Cardiovasc Disord; 2006 Jun; 6():29. PubMed ID: 16780603 [TBL] [Abstract][Full Text] [Related]
14. The evolution of patient-specific precision biomarkers to guide personalized heart-transplant care. Deng MC Expert Rev Precis Med Drug Dev; 2021; 6(1):51-63. PubMed ID: 33768160 [TBL] [Abstract][Full Text] [Related]
15. HEARTBiT: A Transcriptomic Signature for Excluding Acute Cellular Rejection in Adult Heart Allograft Patients. Shannon CP; Hollander Z; Dai DLY; Chen V; Assadian S; Lam KK; McManus JE; Zarzycki M; Kim Y; Kim JV; Balshaw R; Gidlöf O; Öhman J; Smith JG; Toma M; Ignaszewski A; Davies RA; Delgado D; Haddad H; Isaac D; Kim D; Mui A; Rajda M; West L; White M; Zieroth S; Tebbutt SJ; Keown PA; McMaster WR; Ng RT; McManus BM Can J Cardiol; 2020 Aug; 36(8):1217-1227. PubMed ID: 32553820 [TBL] [Abstract][Full Text] [Related]
16. A Changing Paradigm in Heart Transplantation: An Integrative Approach for Invasive and Non-Invasive Allograft Rejection Monitoring. Giarraputo A; Barison I; Fedrigo M; Burrello J; Castellani C; Tona F; Bottio T; Gerosa G; Barile L; Angelini A Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33535640 [TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as non-invasive biomarkers of heart transplant rejection. Duong Van Huyen JP; Tible M; Gay A; Guillemain R; Aubert O; Varnous S; Iserin F; Rouvier P; François A; Vernerey D; Loyer X; Leprince P; Empana JP; Bruneval P; Loupy A; Jouven X Eur Heart J; 2014 Dec; 35(45):3194-202. PubMed ID: 25176944 [TBL] [Abstract][Full Text] [Related]